Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats
- Authors
- Kim, Young-Giun; Lim, Hyung-Ho; Lee, Suh-Ha; Shin, Mal-Soon; Kim, Chang-Ju; Yang, Hyeon Jeong
- Issue Date
- Aug-2015
- Publisher
- SPANDIDOS PUBL LTD
- Keywords
- betaine; streptozotocin; diabetic rats; vascular endothelial growth factor; hypoxia-inducible factor-1 alpha; Akt
- Citation
- MOLECULAR MEDICINE REPORTS, v.12, no.2, pp.1639 - 1644
- Journal Title
- MOLECULAR MEDICINE REPORTS
- Volume
- 12
- Number
- 2
- Start Page
- 1639
- End Page
- 1644
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10290
- DOI
- 10.3892/mmr.2015.3613
- ISSN
- 1791-2997
- Abstract
- Diabetic retinopathy is a severe microvascular complication amongst patients with diabetes, and is the primary cause of visual loss through neovascularization. Betaine is one of the components of Fructus Lycii. In the present study, the effects of betaine on the expression levels of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor (HIF)-1 alpha in association with the Akt pathway were investigated in the retinas of streptozotocin (STZ) -induced diabetic rats using western blot and immunohistochemical analyses. The results of the present study revealed that the expression levels of VEGF, HIF-1 alpha, and Akt were increased in the retinas of the STZ-induced diabetic rats. Betaine treatment attenuated this increase in VEGF and HIF-1 alpha expression via suppression of diabetes-induced Akt activation in the retinas of the diabetic rats. The results suggested that betaine may potentially be used to delay the onset of complications associated with diabetic retinopathy via inhibition of retinal neovascularization in patients with diabetes.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 한의과대학 > 한의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10290)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.